Macro Group logs 21% YoY higher consolidated profits in Q3

Updated 11/2/2022 10:59:00 AM

Arab FinanceMacro Group Pharmaceutical (Macro Capital) (MCRO) posted a 21% year-on-year (YoY) increase in consolidated profit after tax during the third quarter (Q3) of 2022, according to financial indicators filed to the Egyptian Exchange (EGX) on Wednesday.

The company’s net consolidated profit after tax grew to EGP 129.494 million in Q3 2022 from EGP 106.821 million a year earlier.

Revenues surged 25% YoY to EGP 520.301 million in the three months that ended on September 30th.

Moreover, the company’s standalone profit after tax rose by 21% YoY to EGP 128.767 million in Q3 2022.

Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.